Minnesota Senate Bill SF3726

Minnesota 2023-2024 Regular Session

• Introduced: 2/15/24
• Refer: 2/15/24

Caption

Change of ownership fees for persons registered with or licensed by the Board of Pharmacy establishment and specifying that licenses and registrations granted by the Board of Pharmacy are not transferable

Impact

The impact of SF3726 on Minnesota state laws includes amendments to existing statutes regarding pharmacy licensing. By specifying that licenses and registrations granted by the Board of Pharmacy are not transferable, the bill emphasizes the necessity for continued oversight and regulation of pharmacy practices. This will potentially eliminate any confusion regarding the ownership and operation of licensed pharmacies, providing a clear framework for both applicants and regulators. The amendments will likely improve compliance and make the regulatory framework more straightforward, benefiting public health by ensuring licensed pharmacies adhere to established standards.

Summary

SF3726 is a bill aimed at regulating the application and fees associated with the relocation and change of ownership for individuals or businesses licensed or registered with the Board of Pharmacy in Minnesota. The legislation establishes new guidelines that require those registered to submit a new application to the board before relocating their business or changing ownership. The proposed fees are detailed, with some reductions applicable depending on specific circumstances, particularly for those who have remitted previous payments during the fiscal year. This initiative seeks to streamline the process involving the relocation and ownership transfer of pharmacies, which is critical to maintaining state standards in healthcare and pharmacy practice.

Contention

Points of contention associated with SF3726 may revolve around the implementation of new fees and the requirement for applications which could be seen as burdensome, especially for small pharmacy owners or startups. There may be debates regarding the fairness of these fees and their impact on local businesses. Critics may argue that while the intent is to maintain high standards, the additional financial burden could limit opportunities for new entrepreneurs entering the pharmacy market or hinder existing businesses that need to relocate or adjust ownership. Thus, the discussions around the bill could address both regulatory necessity and economic implications for pharmacy businesses.